Relay Therapeutics
Focus: Relay Therapeutics is a Cambridge-based biotech company specializing in motion-based drug design, currently focused on oncology with a pipeline of kinase inhibitors targeting PIK3CA and NRAS mutations. The company operates in the pre-revenue biotech space with early-stage clinical programs.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
13+3 this month
Stable — net +3 jobs in 30d
8 added, 5 removed. Backfill posture.
Should You Work at Relay Therapeutics?
AI assessmentRelay is a high-risk, high-impact opportunity for scientists and clinicians seeking early-stage oncology drug discovery with proprietary technology, but financial runway and funding sustainability are material career risks.
Why Work Here
- Cutting-edge platform: Motion-based drug design is a differentiated approach to target validation and drug discovery in oncology, offering exposure to innovative computational and structural biology techniques.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Random assigned paradigm viewing order
AnxietyClinical Trials (1)
NCT04622527A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study
N/AHelp build intelligence for Relay Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.